News
Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...
A secondary analysis of a large trial shows that exposure to the HIV drug abacavir is linked to an elevated risk for major ...
Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...
Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between US ...
Several Midwestern Cities have been designated as HIV “hotspots” due to the rising number of new cases; and the South ...
Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...
Gilead Sciences, in partnership with the Global Fund, plans to supply a long-acting HIV prevention drug to low-income ...
President John Dramani Mahama has called for a youth-led national conversation on HIV prevention as the country faces a concerning surge in new infections, particularly among young people.
In the mid-nineties, a friend of mine told me that he lost 30 friends and acquaintances to HIV/AIDS in just one week. It was a miracle that he was still alive. Although cases have decreased ...
The results expose a striking prevalence of high-risk sexual behaviours. Over one-third of participants (34.0%) disclosed ...
Millions of lives and decades of progress hang in the balance,” says the president of the International AIDS Society (IAS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results